Amira Boseila | Nanomedicine | Best Researcher Award

Posted on by sciencefather

Dr. Amira Boseila | Nanomedicine | Best Researcher Award

Dr. Amira Boseila, Sinai University, Egypt

Dr. Amira Boseila is a distinguished pharmaceutical researcher and educator at Sinai University, Egypt, with a focus on nanomedicine and targeted drug delivery systems. With a PhD from Cairo University, she has made significant contributions to the field of pharmaceutics, especially in the use of nanocarriers for liver-targeted antiviral drugs. Dr. Boseila continues to lead projects in nanotechnology and drug repurposing for inflammatory and respiratory diseases, demonstrating her commitment to innovative healthcare solutions.

PROFILE

Orcid Profile

Educational Details

Dr. Amira Boseila earned her PhD in Pharmaceutical Sciences from the Faculty of Pharmacy, Cairo University, in February 2020, where her research focused on the use of nanocarriers for targeted drug delivery to the liver. Her Master of Pharmaceutical Sciences was completed in December 2013 at Cairo University, with a thesis on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug, Ondansetron. She also holds a Total Quality Management (TQM) Diploma from the American University of Cairo, obtained in 2009, and a Bachelor of Pharmaceutical Sciences from Cairo University, awarded in 2007 with a grade of “Very Good”.

Professional Experience

Dr. Boseila is currently a full-time lecturer at the Faculty of Pharmacy, Sinai University (since September 2022), where she teaches advanced topics such as Advanced Drug Delivery Systems, Pharmaceutics, and Pharmaceutical Technology. She also holds a post-doctoral research position at the Egyptian Drug Authority, and she has been active in roles such as Associate Researcher and Lead Quality Control Specialist at the National Organization for Drug Control and Research (NODCAR). Dr. Boseila has held various leadership roles, including Head of Comparative Dissolution Unit and Technical Manager of the Physicochemical Lab at the Egyptian Drug Authority. She has also served as a Guest Lecturer at Ain Shams University, teaching a course on Drug Targeting.

Research Interest

Dr. Boseila’s research is centered around nanomedicine, drug targeting, modified-release dosage forms, and the development of novel drug delivery systems. Her focus on quality by design and innovative solutions such as nanocarriers and repurposing drugs for treatments like COVID-19 reflect her dedication to advancing pharmaceutical technology.

Top Notable Publications

Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiota–Gut–Brain Axis

Journal: Antioxidants

Published: October 7, 2024

DOI: 10.3390/antiox13101205

Authors: Mai M. Anwar, Amira A. Boseila, Abeer A. Mabrouk, Abdelfattah A. Abdelkhalek, and Amr Amin​

Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review

Journal: Materials

Published: August 5, 2022

DOI: 10.3390/ma15155392

In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity

Journal: ACS Omega

Published: January 11, 2022

DOI: 10.1021/acsomega.1c05519

Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the “Era of the-Green”: A Systematic Review

Journal: Pharmaceutics

Published: 2022

DOI: 10.3390/pharmaceutics14040844

Conclusion

Dr. Amira Boseila’s impressive academic background, specialized research in nanomedicine and drug delivery systems, extensive professional experience, and significant contributions to pharmaceutical research and healthcare innovation make her a highly suitable candidate for the Best Researcher Award. She meets and exceeds many of the key criteria, such as academic qualifications, impactful research, and leadership in her field.